Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Kent

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Neurology|August 28, 2002
Using bone marrow stromal cells for treatment of strokeDavid A Rempe, Thomas A Kent
Brain : a Journal of Neurology|September 14, 2017
Correlating quantitative susceptibility mapping with cognitive decline in Alzheimer's diseasePaul J Derry, Thomas A Kent
Neurology|April 9, 2008
The time is right to improve organization of stroke careJose I Suarez, Thomas A Kent
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 29, 2006
Hyperglycemia in acute ischemic stroke: a vascular perspectiveSharyl R Martini, Thomas A Kent
Drugs|May 20, 2008
Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directionsPitchaiah Mandava, Perumal Thiagarajan, Thomas A Kent
The Neurologist|July 13, 2004
How important is hyperglycemia during acute brain infarction?Askiel Bruno, Linda S Williams, Thomas A Kent
Stroke|May 21, 2011
Letter by Simard et al regarding article, "Sulfonylurea use before stroke does not influence outcome"J Marc Simard, Thomas A Kent, Hagen Kunte
Neurology|June 26, 2015
Improving early clinical trial phase identification of promising therapeuticsThomas A Kent, Shreyansh D Shah, Pitchaiah Mandava
Current Atherosclerosis Reports|July 9, 2008
Intravenous rt-PA versus endovascular therapy for acute ischemic strokePitchaiah Mandava, Jose I Suarez, Thomas A Kent
Neurology|April 12, 2006
MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour windowPitchaiah Mandava, Jane A Anderson, Thomas A Kent
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Neurology|August 28, 2002
Using bone marrow stromal cells for treatment of strokeDavid A Rempe, Thomas A Kent
Brain : a Journal of Neurology|September 14, 2017
Correlating quantitative susceptibility mapping with cognitive decline in Alzheimer's diseasePaul J Derry, Thomas A Kent
Neurology|April 9, 2008
The time is right to improve organization of stroke careJose I Suarez, Thomas A Kent
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 29, 2006
Hyperglycemia in acute ischemic stroke: a vascular perspectiveSharyl R Martini, Thomas A Kent
Drugs|May 20, 2008
Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directionsPitchaiah Mandava, Perumal Thiagarajan, Thomas A Kent
The Neurologist|July 13, 2004
How important is hyperglycemia during acute brain infarction?Askiel Bruno, Linda S Williams, Thomas A Kent
Stroke|May 21, 2011
Letter by Simard et al regarding article, "Sulfonylurea use before stroke does not influence outcome"J Marc Simard, Thomas A Kent, Hagen Kunte
Neurology|June 26, 2015
Improving early clinical trial phase identification of promising therapeuticsThomas A Kent, Shreyansh D Shah, Pitchaiah Mandava
Current Atherosclerosis Reports|July 9, 2008
Intravenous rt-PA versus endovascular therapy for acute ischemic strokePitchaiah Mandava, Jose I Suarez, Thomas A Kent
Neurology|April 12, 2006
MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour windowPitchaiah Mandava, Jane A Anderson, Thomas A Kent
Pageof 11